Christiane Neumann

78PUBLICATIONS
371CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (78)

|Oct 02, 2026
DOTAM-TCB: Universal Small Molecule-guided Hapten- and T Cell-bispecific Antibodies for Cancer Immunotherapy.

|Jun 29, 2026
The evolving role of cytokines for CAR-T cell manufacturing and beyond.

|Jun 22, 2026
Impact of ASO conjugation and receptor binding affinity on intracellular transport of mono- and bispecific TfR- and CD98-BrainshuttleTM variants.

|Jun 19, 2026
First-in-human study of lomvastomig, a PD-1-TIM-3 bispecific antibody, in patients with advanced and/or metastatic solid tumors.

|Jun 12, 2026
Tobemstomig, a Novel Bispecific Antibody, Preferentially Blocks PD-1 and LAG-3 on CD8 TILs to Expand Stem-like T Cells for Sustained Tumor Control.

|Apr 28, 2026
Engineering of acidic pH-responsive anti-CD3 binding antibodies.

Pageof 13

Frequent Collaborators

16 joint publications

Pablo Umaña

8 joint publications

Johannes Sam

7 joint publications

Sylvia Herter

7 joint publications

Anne Schoenle